Matrixyl Benefits: What the Skincare Research Actually Shows (2026)

Illustrated double-helix diagram in copper and teal, captioned “Matrixyl and collagen synthesis”

Matrixyl Benefits: What the Skincare Research Actually Shows (2026) Matrixyl benefits show up on serum labels next to phrases like “clinically proven,” but the real research is narrower and older than the marketing implies. The trail leads back to a five-amino-acid collagen fragment, identified in a 1993 fibroblast study, later fitted with a fatty tail … Read more

Kisspeptin: Benefits, Mechanism, and Fertility Research (2026)

Illustrated chain of linked amino-acid nodes, captioned “Kisspeptin and GnRH release”

Kisspeptin: Benefits, Mechanism, and Fertility Research (2026) Most claims about kisspeptin peptide benefits skip the one fact that makes this molecule interesting: kisspeptin is not a niche compound invented for wellness marketing, it is the master switch of the human reproductive axis. It sits upstream of the hormones that govern puberty, fertility, and libido, which … Read more

Kentucky Laws About Peptides for Research Purposes: What Actually Applies

Illustrated double-helix diagram in copper and teal, captioned “Kentucky research peptide law, explained”

Kentucky Laws About Peptides for Research Purposes: What Actually Applies Kentucky laws about peptides for research purposes are not one standalone statute; they run through federal drug law under Kentucky pharmacy and controlled-substance statutes, plus one completed federal prosecution showing how the line gets enforced. That matters because RUO (“research use only”) is a federal … Read more

Ipamorelin: Benefits, Mechanism, and What the Research Shows (2026)

Illustrated bar-graph style data graphic, captioned “Ipamorelin: selective GH secretagogue”

Ipamorelin: Benefits, Mechanism, and What the Research Shows (2026) Most claims about ipamorelin benefits describe outcomes that were measured in rats, not in people. Ipamorelin is a synthetic pentapeptide that tells the pituitary to release growth hormone, and it earned attention for doing that cleanly, without the cortisol and prolactin spikes seen with older compounds. … Read more

IGF-1 LR3 Benefits: What the Research Actually Shows (2026)

Illustrated molecular orbit diagram with concentric rings, captioned “IGF-1 LR3 and long-acting IGF signalling”

IGF-1 LR3 Benefits: What the Research Actually Shows (2026) IGF-1 LR3 is an 83-amino-acid analog of native IGF-1 that binds poorly to IGF-binding proteins, giving it a longer half-life than the native peptide. Most claims about IGF-1 LR3 benefits come from bodybuilding forums, not from the laboratory record, and the two tell very different stories. … Read more

Hexarelin: What the Research Shows on Its Mechanism, Benefits, and Legal Status (2026)

Illustrated chain of linked amino-acid nodes, captioned “Hexarelin and GH secretagogue signalling”

Hexarelin: What the Research Shows on Its Mechanism, Benefits, and Legal Status (2026) Hexarelin, also called examorelin, is a six-amino-acid growth-hormone-releasing peptide derived from GHRP-6. Most write-ups on hexarelin peptide benefits jump straight to muscle and recovery claims, but the published record points somewhere more specific: this is one of the most potent growth hormone … Read more

Gonadorelin: Benefits, Mechanism, and Clinical Uses (2026)

Illustrated double-helix diagram in copper and teal, captioned “Gonadorelin and the GnRH-LH-FSH axis”

Gonadorelin: Benefits, Mechanism, and Clinical Uses (2026) Most write-ups on gonadorelin benefits skip the one fact that explains everything: gonadorelin is not a novel designer peptide, it is a synthetic copy of the body’s own gonadotropin-releasing hormone (GnRH). That single detail sets both its documented uses and its hard limits. The compound has a real … Read more